Washington, United States,
08048034981
Gentacan Injection Exporter to Washington, USA, Zimbabwe, New zealand |City Drug Export INDIA
Global Gentacan Injection (Gentamicin) Exporter from India to Washington, USA, Zimbabwe & New Zealand

City Drug Exporters specializes in exporting Gentacan Injection (Gentamicin) from India to international markets including Washington, USA, Zimbabwe, and New Zealand. We provide dependable supply solutions for pharmaceutical wholesalers, distributors, pharmacies, and healthcare procurement companies.

Gentacan Injection (Gentamicin) is an aminoglycoside antibiotic used to treat serious bacterial infections, such as septicemia (blood infections), severe urinary tract infections, respiratory issues like pneumonia, meningitis, and bone or joint infections. It acts by inhibiting bacterial protein synthesis, destroying susceptible pathogens .

Therapeutic Uses :

Gentacan is primarily administered in hospital or clinical settings due to its potency and targeted spectrum against severe pathogens.

Systemic Bacterial Infections: Treats severe blood infections like sepsis or septicemia.

Respiratory Infections: Used for hospital-acquired pneumonia and other complicated lung infections.

Urinary Tract Infections (UTIs): Targets complicated or recurrent kidney and bladder infections.

Central Nervous System Infections: Effective in managing conditions like meningitis.

Bone and Joint Infections: Used to clear stubborn infections in osseous tissues.

Heart/Valvular Infections: Often paired with other antibiotics (like penicillin or vancomycin) to treat endocarditis.


City Drug House Exporters provides:

Bulk supply for hospitals & distributors
Export to USA. Washington, INDIA
Regulatory documents (COA, MSDS, etc.)
Competitive pricing & reliable logistics

Contact for More Information :
📞 Contact City drug House Exporters from India

🌐 Websites:
https://www.citydrugexporters.com

📧 Email: citydrug123@gmail.com

📦 Business Type: Exporter | Bulk Supplier | Distributor

📲 WhatsApp: +91 9975390171
Jul 4th, 2026 5:00 PM

Keywords